Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A (SHG:688212) — Market Cap & Net Worth
Market Cap & Net Worth: Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A (688212)
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A (SHG:688212) has a market capitalization of $700.74 Million (CN¥4.79 Billion) as of May 7, 2026. Listed on the SHG stock exchange, this China-based company holds position #10907 globally and #3221 in its home market, demonstrating a -7.15% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A's stock price CN¥35.56 by its total outstanding shares 134665250 (134.67 Million). Analyse 688212 cash generation efficiency to see how efficiently the company converts income to cash.
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A Market Cap History: 2021 to 2026
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A's market capitalization history from 2021 to 2026. Data shows change from $737.25 Million to $700.74 Million (-1.56% CAGR).
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.06x
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A's market cap is 1.06 times its annual revenue
Latest Price to Earnings (P/E) Ratio
37.68x
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A's market cap is 37.68 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $737.25 Million | $347.05 Million | $57.04 Million | 2.12x | 12.93x |
| 2022 | $1.28 Billion | $445.26 Million | $21.66 Million | 2.88x | 59.21x |
| 2023 | $1.22 Billion | $678.08 Million | $57.85 Million | 1.79x | 21.00x |
| 2024 | $791.78 Million | $749.55 Million | $21.01 Million | 1.06x | 37.68x |
Competitor Companies of 688212 by Market Capitalization
Companies near Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A in the global market cap rankings as of May 7, 2026.
Key companies related to Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #151 globally with a market cap of $150.06 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #211 globally with a market cap of $111.87 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (XETRA:2M6): Ranked #246 globally with a market cap of $99.67 Billion USD ( €85.25 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #151 | Abbott Laboratories | NYSE:ABT | $150.06 Billion | $86.30 |
| #211 | Stryker Corporation | NYSE:SYK | $111.87 Billion | $292.33 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #246 | Medtronic PLC | XETRA:2M6 | $99.67 Billion | €66.40 |
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A Historical Marketcap From 2021 to 2026
Between 2021 and today, Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A's market cap moved from $737.25 Million to $ 700.74 Million, with a yearly change of -1.56%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥700.74 Million | -18.65% |
| 2025 | CN¥861.34 Million | +8.79% |
| 2024 | CN¥791.78 Million | -34.84% |
| 2023 | CN¥1.22 Billion | -5.28% |
| 2022 | CN¥1.28 Billion | +74.01% |
| 2021 | CN¥737.25 Million | -- |
End of Day Market Cap According to Different Sources
On May 7th, 2026 the market cap of Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $700.74 Million USD |
| MoneyControl | $700.74 Million USD |
| MarketWatch | $700.74 Million USD |
| marketcap.company | $700.74 Million USD |
| Reuters | $700.74 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
Shanghai Aohua Photoelectricity Endoscope Co., Ltd. engages in the research and development, manufacture, and sale of electronic endoscope equipment and endoscopic diagnosis and treatment consumables in China and internationally. It offers electronic digestive endoscopes, otolaryngoscopes, bronchoscopes, and endoscopic diagnostic and treatment consumables for use in respiratory medicine, general … Read more